Pyxis Oncology (PYXS) Cash & Equivalents Growth (1y) (2021 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | -68.22% |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | 988.88% |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 214.58% |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | 15.64% |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | 4.77% |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 17.50% |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | -4.13% |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | 3.35% |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 67.78% |
| 10 | Pyxis Oncology | 120.87 Mn | 103.97 Mn | 8.65 Mn | -20.80% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -20.80% |
| Sep 30, 2025 | -26.02% |
| Jun 30, 2025 | -57.19% |
| Mar 31, 2025 | -54.38% |
| Dec 31, 2024 | 101.50% |
| Sep 30, 2024 | -18.07% |
| Jun 30, 2024 | -3.18% |
| Mar 31, 2024 | -47.29% |
| Dec 31, 2023 | -94.61% |
| Sep 30, 2023 | -92.59% |
| Jun 30, 2023 | -88.41% |
| Mar 31, 2023 | -78.53% |
| Dec 31, 2022 | -34.74% |
| Sep 30, 2022 | 48.74% |
| Jun 30, 2022 | 56.77% |
| Mar 31, 2022 | 75.66% |
| Sep 30, 2021 | 1,086.88% |